Checkpoint Therapeutics Inc

Common Stock SEC Reporting - Current
OTCQX U.S. OTCQX Advisor: Ladenburg Thalmann & Co. Inc.
Verified Company Profile 11/03/2016
Contact Info
  • 2 Gansevoort St
  • 9th Floor
  • New York, NY 10014

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001651407
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2014
Employees 6 a/o Sep 30, 2016
Company Officers/Contacts
James F. Oliviero CEO
David J. Horin Interim CFO
Garrett Gray VP, Fin. & Acct.
Company Directors
Michael S. Weiss Chairman
Scott Boilen
Neil Herskowitz
Lindsay Rosenwald
Barry Salzman
Service Providers
OTCQX Advisor
Ladenburg Thalmann & Co. Inc.
4400 Biscayne Boulevard
14th Floor
Miami, FL, 33137

Accounting/Auditing Firm
135 West 50th Street
New York, NY, 10020
United States

Legal Counsel
Alston & Bird, LLP
90 Park Avenue
New York City, NY, 10016
United States

Investor Relations Firm
Not Available
CKPT Security Details
Share Structure
Market Value1 Not Available
Authorized Shares 35,000,000 a/o May 04, 2016
Outstanding Shares 17,015,876 a/o Aug 10, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 12,326,870 a/o May 04, 2016
Par Value Not Available
Transfer Agent(s)
VStock Transfer LLC
Shareholders of Record Not Available
Short Selling Data
Short Interest (%)
Significant Failures to Deliver No

1Market Value calculated only for respective security